SEC Form 4 · STOCK Act

Insider buys that paid off for the people who copied them.

ZeroStack Corp.

+206.0%

Michael Heinrich, Executive Chair, bought $3.5M. Filed Jul 20, 6:31 PM ET.

$1,000 copied at the first price after the filing (Jul 21 open, $1.66) was $3,060 30 trading days later.

Example. Of 339 buys of $100K or more filed Jun 29 to Sep 11, the median lost 5.3% and 67.8% lost money over the same 30 trading days. Not investment advice.

Officers and directors must report their own stock purchases within two business days. We list every one, largest first, with what copying it would have returned.

A free account keeps a watchlist. No password: we email you a link.

4 h delay

Buys Sells Buys and sells Any size $100K+$1M+

Pro filters

CORTSell

CORCEPT THERAPEUTICS INC

James N Wilson · Director

$1.1M−0.9%Oct 16

CORTSell

CORCEPT THERAPEUTICS INC

Roberto Wandenkolk Vieira · President, Oncology

$967K−67.9%Oct 5

CORTSell

CORCEPT THERAPEUTICS INC

Joseph Douglas Lyon · Insider

$1.2M−63.8%Oct 5

CORTSell

CORCEPT THERAPEUTICS INC

Sean Maduck · Insider

$2.9M−71.6%Oct 5

CORTSell

CORCEPT THERAPEUTICS INC

Roberto Wandenkolk Vieira · President, Oncology

$30K−7.0%Sep 18

CORTSell

CORCEPT THERAPEUTICS INC

Joseph Douglas Lyon · Insider

$1.1M−63.8%Sep 16

CORTSell

CORCEPT THERAPEUTICS INC

James N Wilson · Director

$1.1M−0.9%Sep 16

CORTSell

CORCEPT THERAPEUTICS INC

Sean Maduck · Insider

$2.9M−71.9%Sep 3

CORTSell

CORCEPT THERAPEUTICS INC

Roberto Wandenkolk Vieira · President, Oncology

$6.5M−93.2%Sep 3

CORTSell

CORCEPT THERAPEUTICS INC

Kimberly Park · Director

$3.3M−100.0%Aug 28

CORTSell

CORCEPT THERAPEUTICS INC

Sean Maduck · Insider

$3.9M−76.0%Aug 27

CORTSell

CORCEPT THERAPEUTICS INC

David L Mahoney · Director

$12.3M−8.4%Aug 20

CORTSell

CORCEPT THERAPEUTICS INC

Sean Maduck · Insider

$419K−27.3%Aug 18

CORTSell

CORCEPT THERAPEUTICS INC

James N Wilson · Director

$1.1M−0.9%Aug 18

CORTSell

CORCEPT THERAPEUTICS INC

Gary Charles Robb · Chief Business Officer

$1.2M−20.1%Aug 18

CORTSell

CORCEPT THERAPEUTICS INC

Sean Maduck · Insider

$118K−9.6%Aug 12

CORTSell

CORCEPT THERAPEUTICS INC

William Guyer · Chief Development Officer

$1.8M−80.4%Aug 12

CORTSell

CORCEPT THERAPEUTICS INC

William Guyer · Chief Development Officer

$419K−48.1%Aug 6

CORTSell

CORCEPT THERAPEUTICS INC

Sean Maduck · Insider

$2.3M−67.5%Aug 5

CORTSell

CORCEPT THERAPEUTICS INC

Joseph Douglas Lyon · Insider

$176K−21.9%Aug 5

CORTSell

CORCEPT THERAPEUTICS INC

Atabak Mokari · Chief Financial Officer

$9.2M−83.2%Aug 3

CORTSell

CORCEPT THERAPEUTICS INC

James N Wilson · Director

$883K−0.9%Jul 17

CORTSell

CORCEPT THERAPEUTICS INC

Atabak Mokari · Chief Financial Officer

$3.5M−71.3%Jul 17

CORTSell

CORCEPT THERAPEUTICS INC

William Guyer · Chief Development Officer

$1.9M−83.4%Jul 8

CORTSell

CORCEPT THERAPEUTICS INC

Sean Maduck · Insider

$2.2M−71.9%Jul 6

CORTSell

CORCEPT THERAPEUTICS INC

James N Wilson · Director

$832K−0.9%Jun 18

CORTSell

CORCEPT THERAPEUTICS INC

David L Mahoney · Director

$1.7M−43.3%Jun 18

CORTSell

CORCEPT THERAPEUTICS INC

Atabak Mokari · Chief Financial Officer

$3.2M−71.3%Jun 17

CORTSell

CORCEPT THERAPEUTICS INC

William Guyer · Chief Development Officer

$1.4M−83.4%Jun 4

CORTSell

CORCEPT THERAPEUTICS INC

Sean Maduck · Insider

$1.8M−73.6%Jun 3

CORTSell

CORCEPT THERAPEUTICS INC

Atabak Mokari · Chief Financial Officer

$2.8M−72.4%Jun 3

CORTSell

CORCEPT THERAPEUTICS INC

Joseph K Belanoff · Chief Executive Officer

$895K−0.5%Jun 2

CORTSell

CORCEPT THERAPEUTICS INC

Joseph Douglas Lyon · Insider

$325K−44.5%May 29

CORTSell

CORCEPT THERAPEUTICS INC

Sean Maduck · Insider

$4.9M−89.3%May 29

CORTSell

Corcept Therapeutics Inc

William Guyer · Chief Development Officer

$1.0M−90.0%May 7

CORTSell

Corcept Therapeutics Inc

Joseph K Belanoff · CEO

$2.0M−1.0%May 5

CORTSell

Corcept Therapeutics Inc

William Guyer · Chief Development Officer

$819K−90.0%Apr 8

CORTSell

Corcept Therapeutics Inc

Joseph K Belanoff · CEO

$1.3M−1.0%Mar 27

CORTSell

Corcept Therapeutics Inc

William Guyer · Chief Development Officer

$424K−84.0%Mar 24

CORTSell

Corcept Therapeutics Inc

William Guyer · Chief Development Officer

$296K−79.0%Mar 6

CORTSell

Corcept Therapeutics Inc

William Guyer · Chief Development Officer

$817K−94.0%Feb 5

CORTSell

Corcept Therapeutics Inc

William Guyer · Chief Development Officer

$704K−94.0%Jan 8

CORTSell

Corcept Therapeutics Inc

Joseph K Belanoff · CEO

$3.2M−1.0%Dec 3

CORTSell

Corcept Therapeutics Inc

Sean Maduck · Insider

$1.6M−15.0%Dec 3

CORTSell

Corcept Therapeutics Inc

Joseph Douglas Lyon · Insider

$398K−32.0%Dec 3

CORTSell

Corcept Therapeutics Inc

William Guyer · Chief Development Officer

$1.6M−94.0%Dec 3

CORTSell

Corcept Therapeutics Inc

William Guyer · Chief Development Officer

$364K−85.0%Dec 3

CORTSell

Corcept Therapeutics Inc

Gary Charles Robb · Chief Business Officer

$147K−6.0%Nov 26

CORTSell

Corcept Therapeutics Inc

Joseph Douglas Lyon · Insider

$80K−14.0%Nov 26

CORTSell

Corcept Therapeutics Inc

Daniel N Swisher Jr · Director

$132K−100.0%Nov 13

Older filings

Filings come from SEC EDGAR within a minute of the SEC accepting them. Without Pro, each one unlocks 4 hours later. Not investment advice.

Questions

Where does the data come from?

Corporate insider trades come straight from SEC Form 4 filings, pulled from EDGAR within a minute of each filing. Congress trades come from STOCK Act disclosures. All of it is public and free to browse here, and Pro sees the newest filings first.

How often is it updated?

Every minute from 6 AM to 10 PM New York time on weekdays, the hours the SEC accepts filings. Pro sees each filing as it lands. Without Pro, a filing unlocks 4 hours after the SEC accepts it.

Is following insider trades legal?

Yes. Insiders are legally required to disclose their trades within a few days. Acting on those public disclosures is completely legal. Trading on private, non-public information is illegal, but that's a different thing.

What does the iPhone app add?

We're building an iPhone app that alerts you to new filings and, if you choose, copies a buy into your own brokerage after you approve it. It isn't out yet, and the waitlist is free.